Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.
Corbus Pharmaceuticals Holdings Inc. (CRBP) shares rose 6.76% to $12.01 on Tuesday, despite a general market downturn. The NASDAQ fell 1.21% and the Dow Jones dropped 1.07%. This marks the second consecutive day of gains for Corbus, though it remains 41.59% below its 52-week high. Compared to competitors, Vanda Pharmaceuticals rose 21.59%, Fortress Biotech increased 2.30%, and Viking Therapeutics fell 1.20%. Trading volume was higher than the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments